Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Net Income (2020 - 2025)

Historic Net Income for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to -$9.8 million.

  • RxSight's Net Income fell 5487.54% to -$9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$35.7 million, marking a year-over-year decrease of 1640.28%. This contributed to the annual value of -$27.5 million for FY2024, which is 4351.78% up from last year.
  • As of Q3 2025, RxSight's Net Income stood at -$9.8 million, which was down 5487.54% from -$11.8 million recorded in Q2 2025.
  • In the past 5 years, RxSight's Net Income registered a high of -$5.9 million during Q4 2024, and its lowest value of -$17.6 million during Q1 2022.
  • Moreover, its 5-year median value for Net Income was -$12.4 million (2023), whereas its average is -$11.6 million.
  • In the last 5 years, RxSight's Net Income crashed by 15988.97% in 2021 and then soared by 5596.2% in 2024.
  • RxSight's Net Income (Quarter) stood at -$15.7 million in 2021, then grew by 0.86% to -$15.6 million in 2022, then skyrocketed by 41.21% to -$9.2 million in 2023, then surged by 35.3% to -$5.9 million in 2024, then tumbled by 65.28% to -$9.8 million in 2025.
  • Its Net Income was -$9.8 million in Q3 2025, compared to -$11.8 million in Q2 2025 and -$8.2 million in Q1 2025.